BioNTech Results Presentation Deck slide image

BioNTech Results Presentation Deck

Harnessing the Power of the Immune System to Address Serious Diseases ● 1 MARKETED VACCINE 8 Infectious Disease 1 PHASE 1 PROGRAM Validated mRNA technology • Flexible & adaptable platform • Speed in clinical development ● Global manufacturing network • Large safety database with proven path to regulatory approval Focus on significant global health needs, including COVID- 19¹, malaria², HIV³, TB³, influenza¹ 9 PRECLINICAL PROGRAMS Broaden Disease Horizon: ● ¹Collaboration with Pfizer; 2Collaboration with KENUP Foundation; ³Collaboration with Bill & Melinda Gates Foundation ● ● 15 PROGRAMS IN 19 CLINICAL TRIALS Oncology 4 RANDOMIZED PHASE 2 PROGRAMS Sophisticated toolbox of technologies across 4 drug classes Diverse and complementary modes of action Novel therapeutic targets Potential for synergistic combinations Single agent objective responses in multiple Phase 1 trials. Focus on broad range of solid tumors with the potential to improve treatment paradigms Autoimmune and inflammatory diseases, regenerative medicine BIONTECH
View entire presentation